Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JENNIFER KATE PEACOCK

Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Pediatrics

NPI
1417340035
CMS profile
10667571
Location
DALLAS, TX

General Payments · PY2021–2024

$1,212.30

  • Reported across 61 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$293.97

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $293.97 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GENZYME CORPORATION $120.98 4
Takeda Pharmaceuticals U.S.A., Inc. $61.41 4
Mirum Pharmaceuticals, Inc. $56.84 3
ABIOMED $40.88 2
Ipsen Biopharmaceuticals, Inc $13.86 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $469.95 26
PY2022 $292.61 13
PY2023 $155.77 8
PY2024 $293.97 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABIOMED $23.93 07/02/2024 Food and Beverage Undisputed 01/23/2026 1142306201 CMS
ABIOMED $16.95 07/26/2024 Food and Beverage Undisputed 01/23/2026 1142306203 CMS
GENZYME CORPORATION $29.57 02/29/2024 Food and Beverage Undisputed 01/23/2026 1139986796 CMS
GENZYME CORPORATION $36.17 05/16/2024 Food and Beverage Undisputed 01/23/2026 1139986808 CMS
GENZYME CORPORATION $25.01 06/05/2024 Food and Beverage Undisputed 01/23/2026 1139986812 CMS
GENZYME CORPORATION $30.23 12/12/2024 Food and Beverage Undisputed 01/23/2026 1139986830 CMS
Ipsen Biopharmaceuticals, Inc $13.86 12/03/2024 Food and Beverage Undisputed 01/23/2026 1091991717 CMS
Mirum Pharmaceuticals, Inc. $18.56 08/08/2024 Food and Beverage Undisputed 01/23/2026 1123326109 CMS
Mirum Pharmaceuticals, Inc. $18.21 09/26/2024 Food and Beverage Undisputed 01/23/2026 1123326113 CMS
Mirum Pharmaceuticals, Inc. $20.07 12/19/2024 Food and Beverage Undisputed 01/23/2026 1123326111 CMS
Takeda Pharmaceuticals U.S.A., Inc. $17.29 08/15/2024 Food and Beverage Undisputed 01/23/2026 1137805931 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.27 10/10/2024 Food and Beverage Undisputed 01/23/2026 1137805933 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.86 11/14/2024 Food and Beverage Undisputed 01/23/2026 1137805935 CMS
Takeda Pharmaceuticals U.S.A., Inc. $13.99 12/05/2024 Food and Beverage Undisputed 01/23/2026 1137805937 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.